Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

PURPOSE: We sought to determine whether the combination of ixabepilone plus capecitabine improved overall survival (OS) compared with capecitabine alone in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes. PATIENTS AND METHODS: A total of 1,221 patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sparano, Joseph A., Vrdoljak, Eduard, Rixe, Oliver, Xu, Binghe, Manikhas, Alexey, Medina, Carlos, Ventilari Da Costa, Susanne Crocamo, Ro, Jungsil, Rubio, Gonzalo, Rondinon, Monica, Perez Manga, Gumersindo, Peck, Ronald, Poulart, Valerie, Conte, Pierfranco
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2010
Materias:
Original Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903325/
https://ncbi.nlm.nih.gov/pubmed/20530276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.4244
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares